Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

PHASE3CompletedINTERVENTIONAL
Enrollment

476

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

December 19, 2017

Study Completion Date

May 5, 2018

Conditions
DiphtheriaTetanusPertussisPoliomyelitis
Interventions
BIOLOGICAL

DTaP-IPV combination vaccine

0.5-mL IM

BIOLOGICAL

DTaP vaccine and IPV vaccine

0.5-mL IM

Trial Locations (20)

Unknown

Inje University Busan Paik Hospital, Busan

KeiMyung University Dongsan Medical Center, Daegu

Gwangmyeong Sungae Hospital, Gyeonggi-do

Wonkwang University Hospital, Iksan

Inha University Hospital, Incheon

Pusan National University Yangsan Hospital, Pusan

Asan Medical Center, Seoul

Cheil General Hospital, Seoul

Chung-Ang University Hospital, Seoul

Eulgi General Hospital, Seoul

Gangnam Sevrance Christian Hospital, Seoul

Hallym University Medical Center, Seoul

KEPCO Medical Center, Seoul

Korea Cancer Center Hospital, Seoul

KyungHee University Hospital at Gangdong, Seoul

KyungHee University Hospital, Seoul

Samsung Medical Center, Seoul

Wonju Sevrance Christian Hospital, Wŏnju

Siriraj Hospital, Bangkok

Thammasat University, Bangkok

All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY